Deficient O
Functioning O
of O
Fronto-Striatal O
Circuits O
During O
the O
Resolution O
of O
Cognitive O
Conflict O
in O
Cannabis-Using O
Youth O
Objective O
: O
Disturbances O
in O
self-regulatory O
control O
are O
involved O
in O
the O
initiation O
and O
maintenance O
of O
addiction O
, O
including O
cannabis O
use O
disorder O
( O
CUD O
) O
. O

In O
adults O
, O
chronic O
cannabis O
use O
is O
associated O
with O
disturbances O
in O
fronto-striatal O
circuits O
during O
tasks O
that O
require O
the O
engagement O
of O
self-regulatory O
control O
, O
including O
the O
resolution O
of O
cognitive O
conflict O
. O

Understudied O
are O
the O
behavioral O
and O
neural O
correlates O
of O
these O
processes O
earlier O
in O
the O
course O
of O
cannabis O
use O
, O
disentangled O
from O
effects O
of O
long-term O
use O
. O

The O
present O
study O
investigates O
the O
functioning O
of O
fronto-striatal O
circuits O
during O
the O
resolution O
of O
cognitive O
conflict O
in O
cannabis-using O
youth O
. O

Method O
: O
Functional O
magnetic O
resonance O
imaging O
data O
was O
acquired O
from O
28 O
cannabis-using O
( O
CU O
) O
youth O
and O
32 O
age-matched O
healthy O
participants O
( O
HC O
) O
during O
the O
performance O
of O
a O
Simon O
task O
. O

General O
linear O
modeling O
was O
used O
to O
compare O
patterns O
of O
brain O
activation O
during O
correct O
responses O
to O
conflict O
stimuli O
across O
groups O
. O

Psychophysiological O
interaction O
analyses O
were O
used O
to O
examine O
conflict-related O
fronto-striatal O
connectivity O
across O
groups O
. O

Associations O
of O
fronto-striatal O
activation O
and O
connectivity O
with O
cannabis O
use O
measures O
were O
explored O
. O

Results O
: O
Reduced O
conflict-related O
activity O
was O
detected O
in O
CU O
relative O
to O
HC O
youth O
in O
fronto-striatal O
regions O
, O
including O
ventromedial O
prefrontal O
cortex O
( O
vmPFC O
) O
, O
striatum O
, O
pallidum O
and O
thalamus O
. O

Fronto-striatal O
connectivity O
did O
not O
differ O
across O
groups O
, O
but O
negative O
connectivity O
between O
vmPFC O
and O
striatum O
was O
detected O
in O
both O
groups O
. O

Conclusion O
: O
These O
findings O
are O
consistent O
with O
previous O
reports O
of O
cannabis-associated O
disturbances O
in O
fronto-striatal O
circuits O
in O
adults O
and O
point O
to O
the O
specific O
influence O
of O
cannabis O
on O
neurodevelopmental O
changes O
in O
youth O
. O

Future O
studies O
should O
examine O
whether O
fronto-striatal O
functioning O
is O
a O
reliable O
marker O
of O
CUD O
severity O
and O
potential O
target O
for O
circuit-based O
interventions O
. O

METHOD O
Participants O
Participants O
were O
28 O
adolescents O
and O
emerging O
adults O
with O
significant O
cannabis O
use O
( O
CU O
) O
and O
32 O
healthy O
controls O
( O
HC O
) O
, O
aged O
14–23 O
years O
, O
group O
matched O
on O
age O
, O
gender O
, O
socioeconomic O
status O
( O
SES O
) O
, O
race O
and O
ethnicity O
. O

Demographics O
for O
all O
participants O
and O
clinical O
ratings O
for O
the O
CU O
group O
are O
shown O
in O
Table O
1 O
. O

Participants O
were O
recruited O
through O
flyers O
, O
Internet O
advertisements O
, O
word-of-mouth O
, O
and O
local O
mental O
health O
clinics O
and O
schools O
. O

This O
study O
aimed O
to O
assess O
the O
functioning O
of O
fronto-striatal O
circuits O
early O
in O
the O
course O
of O
a O
problematic O
cannabis O
use O
trajectory O
. O

DSM O
diagnostic O
criteria O
poorly O
capture O
the O
patterns O
, O
consequences O
, O
and O
severity O
of O
cannabis O
use O
in O
youth O
and O
teens O
often O
experience O
impairment O
without O
meeting O
criteria O
for O
DSM-IV O
substance O
abuse/dependence O
or O
a O
DSM-5 O
SUD O
. O

Thus O
, O
inclusion O
in O
the O
CU O
group O
required O
meeting O
at O
least O
one O
DSM-IV O
diagnostic O
criterion O
. O

Because O
it O
is O
possible O
that O
infrequent O
cannabis O
use O
may O
not O
be O
associated O
with O
neural O
changes O
, O
inclusion O
in O
the O
CU O
group O
required O
“ O
moderate O
” O
use O
defined O
as O
at O
least O
twice O
weekly O
. O

CU O
participants O
were O
excluded O
if O
they O
had O
a O
lifetime O
diagnosis O
of O
SUD O
( O
dependence O
or O
abuse O
) O
other O
than O
cannabis O
or O
if O
any O
substance O
other O
than O
cannabis O
( O
THC O
) O
was O
detected O
by O
a O
urine O
drug O
test O
( O
Construction O
12-Drug O
Screen O
Test O
, O
Innovacon O
, O
Inc. O
, O
San O
Diego O
, O
CA O
) O
administered O
on O
the O
day O
of O
the O
scan O
. O

In O
addition O
, O
CU O
participants O
were O
asked O
to O
abstain O
at O
least O
12 O
hours O
prior O
to O
assessment/scanning O
. O

It O
should O
be O
noted O
, O
however O
, O
that O
urine O
drug O
testing O
was O
not O
used O
to O
determine O
cannabis O
use O
abstinence O
prior O
to O
scanning O
because O
THC O
can O
be O
detected O
in O
urine O
beyond O
12 O
hours O
after O
use O
. O

HC O
participants O
did O
not O
meet O
DSM-IV O
criteria O
for O
any O
SUD O
and O
had O
no O
history O
of O
cannabis O
use O
. O

Cannabis O
use O
and O
DSM O
criteria O
for O
cannabis-related O
disorders O
were O
assessed O
with O
the O
Comprehensive O
Adolescent O
Severity O
Inventory O
( O
CASI-A O
) O
, O
the O
Timeline O
Follow-Back O
( O
TLFB O
) O
, O
the O
Structured O
Clinical O
Interview O
for O
DSM-IV O
Axis-I O
Disorders O
( O
SCID-I O
) O
for O
participants O
18 O
years O
and O
older O
, O
and O
the O
Kiddie-Schedule O
for O
Affective O
Disorders O
and O
Schizophrenia-Present O
and O
Lifetime O
Version O
( O
K-SADS-PL O
) O
for O
those O
under O
18 O
years O
. O

Participants O
with O
a O
history O
of O
neurological O
illness O
, O
past O
seizures O
, O
head O
trauma O
with O
loss O
of O
consciousness O
, O
mental O
retardation O
, O
developmental O
disorder O
, O
or O
Axis O
I O
psychiatric O
disorders O
were O
excluded O
. O

Depressive O
, O
anxiety O
and O
attention O
deficit O
hyperactivity O
( O
ADHD O
) O
disorders O
were O
permitted O
in O
the O
CU O
group O
, O
given O
their O
high O
co-morbidity O
with O
moderate O
to O
heavy O
cannabis O
use O
in O
youth O
. O

The O
presence O
of O
these O
and O
other O
Axis O
1 O
disorders O
was O
determined O
based O
on O
the O
SCID-I O
or O
K-SADS-PL O
. O

The O
DuPaul-Barkley O
Attention-Deficit O
Hyperactivity O
Disorder O
Rating O
Scale O
quantified O
symptoms O
of O
inattention O
and O
hyperactivity O
. O

Full-scale O
IQs O
were O
estimated O
using O
the O
Wechsler O
Abbreviated O
Scale O
of O
Intelligence O
( O
WASI O
) O
, O
and O
SES O
was O
calculated O
based O
on O
parental O
academic O
and O
occupational O
achievement O
using O
the O
Modified O
Hollingshead O
4-Factor O
Index O
. O

All O
clinical O
data O
were O
reviewed O
and O
confirmed O
by O
a O
psychiatrist O
who O
also O
conducted O
clinical O
interviews O
for O
all O
participants O
. O

Adult O
participants O
provided O
informed O
consent O
. O

Minor O
participants O
provided O
assent O
, O
and O
their O
caregivers O
provided O
consent O
. O

The O
research O
protocol O
was O
approved O
by O
the O
Institutional O
Review O
Board O
of O
the O
New O
York O
State O
Psychiatric O
Institute O
. O

FMRI O
Paradigm O
Participants O
completed O
the O
Simon O
task O
( O
previously O
described O
) O
. O

Briefly O
, O
participants O
were O
presented O
with O
a O
leftward O
or O
rightward O
pointing O
arrow O
on O
each O
trial O
that O
was O
either O
congruent O
or O
incongruent O
with O
its O
position O
( O
left O
or O
right O
) O
on O
the O
screen O
. O

They O
were O
instructed O
to O
respond O
as O
quickly O
and O
accurately O
as O
possible O
to O
the O
direction O
of O
the O
arrow O
by O
pressing O
a O
button O
on O
a O
response O
box O
using O
the O
index O
finger O
for O
left O
and O
the O
middle O
finger O
for O
right O
. O

Stimulus O
duration O
was O
1300 O
ms O
, O
with O
jittered O
intervals O
ranging O
from O
4160 O
to O
6960 O
ms O
( O
M=5350 O
, O
SD=1159.98 O
) O
between O
each O
trial O
. O

Each O
of O
3 O
runs O
consisted O
of O
55 O
trials O
, O
with O
11 O
blank O
, O
22 O
congruent O
, O
and O
22 O
incongruent O
stimuli O
. O

E-prime O
software O
( O
Psychology O
Software O
Tools O
, O
Inc. O
, O
Sharpsburg O
, O
Pa. O
) O
was O
used O
to O
program O
and O
run O
the O
experiment O
and O
to O
record O
participants O
’ O
responses O
and O
reaction O
times O
( O
RTs O
) O
. O

Behavioral O
Analyses O
RTs O
on O
correct O
trials O
were O
entered O
as O
dependent O
variables O
in O
a O
repeated O
measures O
, O
mixed-model O
ANOVA O
in O
IBM O
SPSS O
Statistics O
22.0 O
( O
Armonk O
, O
NY O
: O
IBM O
Corp. O
) O
with O
Stimulus O
( O
post-congruent O
Incongruent O
vs. O
post-congruent O
Congruent O
) O
as O
the O
within-subject O
variable O
and O
group O
( O
CU O
vs. O
HC O
) O
as O
the O
between-subject O
variable O
. O

Image O
Acquisition O
and O
Processing O
Images O
were O
collected O
using O
a O
GE O
Signa O
3 O
Tesla O
LC O
scanner O
( O
Milwaukee O
, O
WI O
) O
. O

Functional O
images O
were O
acquired O
using O
a O
T2 O
* O
sensitive O
, O
gradient-recalled O
, O
single O
shot O
, O
echo-planar O
pulse O
sequence O
( O
repetition O
time O
= O
2200 O
ms O
, O
echo O
time O
= O
30 O
ms O
, O
90 O
degree O
flip O
angle O
, O
single O
excitation O
per O
image O
, O
24 O
* O
24 O
cm O
field O
of O
view O
, O
64 O
* O
64 O
matrix O
, O
34 O
slices O
3.5mm O
thick O
, O
no O
gap O
, O
covering O
the O
entire O
brain O
) O
. O

We O
collected O
140 O
echo-planar O
imaging O
( O
EPI O
) O
volumes O
for O
each O
run O
. O

Image O
preprocessing O
and O
first-level O
analyses O
were O
carried O
out O
using O
SPM12 O
( O
http O
: O
//www.fil.ion.ucl.ac.uk/spm/ O
) O
and O
MATLAB O
9.0 O
( O
Mathworks O
, O
Natick O
, O
MA O
) O
. O

Functional O
images O
were O
corrected O
for O
differences O
in O
slice O
timing O
using O
sinc-interpolation O
, O
and O
head O
movement O
was O
corrected O
using O
a O
least-squares O
approach O
and O
a O
6-parameter O
rigid O
body O
spatial O
transformation O
. O

Structural O
data O
were O
coregistered O
to O
the O
functional O
data O
and O
segmented O
into O
tissue O
probability O
maps O
, O
bias O
corrected O
and O
spatially O
normalized O
to O
the O
Montreal O
Neurological O
Institute O
( O
MNI O
) O
space O
of O
1 O
× O
1 O
× O
1 O
mm3 O
voxels O
. O

Using O
the O
deformation O
fields O
of O
these O
segmented O
images O
, O
the O
functional O
images O
were O
subsequently O
spatially O
normalized O
to O
MNI O
space O
of O
and O
3 O
× O
3 O
× O
3 O
mm3 O
voxels O
. O

An O
8-mm O
full-width/half-maximum O
isotropic O
Gaussian O
smoothing O
kernel O
was O
applied O
to O
all O
normalized O
functional O
images O
. O

All O
analyses O
included O
a O
temporal O
high-pass O
filter O
( O
128 O
s O
) O
and O
correction O
for O
temporal O
autocorrelation O
using O
an O
autoregressive O
AR O
( O
1 O
) O
model O
. O

Each O
image O
was O
scaled O
to O
have O
a O
global O
mean O
intensity O
of O
100 O
. O

For O
each O
participant O
, O
preprocessed O
time O
series O
data O
from O
all O
three O
Simon O
task O
runs O
( O
420 O
volumes O
) O
were O
modeled O
using O
a O
General O
Linear O
Model O
( O
GLM O
) O
with O
six O
conditions O
: O
1 O
) O
Incongruent O
correct O
trials O
preceded O
by O
congruent O
trials O
( O
cI O
) O
, O
2 O
) O
Congruent O
correct O
trials O
preceded O
by O
incongruent O
trials O
( O
iC O
) O
, O
3 O
) O
Incongruent O
correct O
trials O
preceded O
by O
incongruent O
trials O
( O
iI O
) O
, O
4 O
) O
Congruent O
correct O
trials O
preceded O
by O
congruent O
trials O
( O
cC O
) O
, O
5 O
) O
fixation O
trials O
, O
and O
6 O
) O
incorrect O
trials O
( O
incongruent O
or O
congruent O
) O
, O
including O
those O
trials O
with O
RTs O
below O
the O
minimum O
RT O
of O
200 O
ms O
required O
for O
stimulus O
detection O
and O
processing O
. O

Because O
of O
the O
limited O
number O
of O
incorrect O
trials O
, O
contrasts O
involving O
these O
trials O
were O
not O
assessed O
. O

All O
of O
the O
task O
regressors O
were O
convolved O
with O
the O
canonical O
HRF O
, O
and O
least-squares O
regression O
was O
used O
to O
estimate O
parameters O
for O
each O
independent O
variable O
for O
each O
participant O
. O

To O
ensure O
that O
the O
non-significant O
motion O
differences O
could O
not O
account O
for O
our O
results O
, O
we O
included O
24 O
nuisance O
motion O
regressors O
as O
covariates O
of O
non-interest O
to O
capture O
linear O
, O
quadratic O
, O
differential O
, O
and O
quadratic O
differential O
motion O
. O

Runs O
in O
which O
a O
participant O
had O
more O
than O
30 O
% O
error O
rate O
( O
ER O
) O
on O
the O
task O
or O
more O
than O
3mm O
of O
total O
displacement O
in O
any O
of O
the O
6 O
standard O
motion O
parameters O
, O
following O
conversion O
of O
rotational O
parameters O
to O
distances O
by O
computing O
the O
arc O
length O
displacement O
on O
the O
surface O
of O
a O
sphere O
with O
radius O
50 O
mm O
, O
were O
considered O
poor O
quality O
data O
and O
excluded O
from O
our O
analyses O
. O

Conflict-related O
Activation O
Parameter O
estimates O
averaged O
across O
the O
3 O
runs O
were O
used O
to O
produce O
an O
incongruent O
( O
cI O
and O
cC O
) O
versus O
congruent O
( O
cC O
and O
iC O
) O
contrast O
( O
I-C O
) O
for O
each O
participant O
to O
isolate O
brain O
activation O
associated O
with O
the O
engagement O
of O
self-regulatory O
control O
and O
resolution O
of O
cognitive O
conflict O
( O
i.e. O
, O
interference O
effect O
) O
. O

The O
I-C O
parameter O
estimates O
maps O
were O
compared O
across O
groups O
in O
a O
second-level O
GLM O
adjusting O
for O
age O
and O
gender O
, O
using O
the O
two-sample O
t-test O
function O
with O
covariates O
implemented O
in O
SPM12 O
. O

A O
voxel-wise O
cluster-defining O
threshold O
( O
CDT O
) O
of O
p O
< O
.001 O
was O
applied O
whole-brain O
, O
and O
minimum O
cluster O
extent O
for O
significance O
at O
a O
Family O
Wise O
Error O
( O
FWE O
) O
rate O
of O
p O
< O
.05 O
was O
determined O
by O
the O
FWEc O
cluster-level O
correction O
for O
multiple O
comparison O
function O
implemented O
in O
SPM12 O
. O

Conflict-related O
Functional O
Connectivity O
To O
further O
assess O
the O
functioning O
of O
fronto-striatal O
circuits O
involved O
in O
the O
resolution O
of O
cognitive O
conflict O
in O
CU O
relative O
to O
HC O
, O
we O
investigated O
group O
differences O
in O
conflict-related O
functional O
connectivity O
. O

To O
do O
so O
, O
we O
computed O
a O
psychophysiological O
interaction O
( O
PPI O
) O
of O
the O
trial-by-trial O
psychometric O
estimate O
of O
conflict O
( O
I-C O
) O
by O
the O
physiological O
activation O
during O
I-C O
trials O
in O
a O
functionally O
defined O
frontal O
seed O
. O

The O
seed O
was O
defined O
as O
a O
6-mm-radius O
sphere O
centered O
on O
the O
coordinates O
where O
maximal O
group O
differences O
in O
I-C O
activation O
were O
found O
within O
the O
vmPFC O
. O

We O
then O
regressed O
this O
PPI O
term O
against O
whole-brain O
activation O
maps O
to O
identify O
regions O
in O
which O
coupling O
with O
the O
vmPFC O
varied O
as O
a O
function O
of O
conflict O
( O
I-C O
) O
. O

Positive O
and O
negative O
connectivity O
are O
respectively O
defined O
as O
significant O
positive O
and O
negative O
correlations O
between O
regions O
’ O
timeseries O
. O

Regions O
in O
which O
timeseries O
are O
uncorrelated O
are O
considered O
unconnected O
. O

A O
second-level O
analysis O
was O
conducted O
to O
test O
group O
differences O
in O
conflict-related O
functional O
connectivity O
, O
adjusting O
for O
age O
and O
gender O
. O

Because O
of O
our O
a O
priori O
hypotheses O
of O
fronto-striatal O
disturbances O
, O
these O
group-level O
analyses O
of O
connectivity O
with O
vmPFC O
were O
restricted O
to O
the O
striatal O
voxels O
within O
the O
caudate O
and O
putamen O
as O
defined O
by O
the O
AAL O
atlas O
. O

A O
voxel-wise O
CDT O
of O
p O
< O
.001 O
was O
applied O
to O
the O
second-level O
t-maps O
, O
and O
minimum O
cluster O
extent O
for O
significance O
at O
a O
FWE O
rate O
of O
p O
< O
.05 O
was O
determined O
by O
the O
FWEc O
cluster-level O
correction O
for O
multiple O
comparison O
function O
implemented O
in O
SPM12 O
. O

Findings O
that O
did O
not O
survive O
FWEc O
correction O
are O
reported O
as O
uncorrected O
. O

Clinical O
Correlates O
In O
the O
CU O
group O
, O
correlation O
analyses O
were O
conducted O
to O
examine O
the O
relationships O
of O
conflict-related O
activation O
and O
connectivity O
with O
cannabis O
use O
. O

Each O
participant O
’ O
s O
average O
activation O
and O
connectivity O
estimates O
were O
extracted O
from O
each O
cluster O
that O
was O
determined O
to O
be O
significant O
in O
our O
second-level O
group O
analyses O
. O

Pearson O
’ O
s O
coefficients O
were O
then O
computed O
between O
these O
estimates O
and O
the O
1 O
) O
age O
of O
first O
regular O
cannabis O
use O
, O
2 O
) O
duration O
of O
use O
( O
in O
years O
) O
,3 O
) O
days O
of O
use O
in O
the O
past O
30 O
days O
, O
and O
4 O
) O
days O
of O
abstinence O
prior O
to O
scanning O
. O

Potential O
Confounding O
Effects O
To O
assess O
potential O
confounding O
effects O
of O
comorbidity O
in O
the O
CU O
group O
, O
I-C O
activation O
maps O
were O
compared O
across O
groups O
in O
additional O
second-level O
two-sample O
t-tests O
( O
FWEc O
) O
after O
excluding O
CU O
participants O
with O
comorbid O
1 O
) O
attention-deficit/hyperactivity O
disorder O
( O
ADHD O
) O
, O
2 O
) O
major O
depressive O
disorder O
( O
MDD O
) O
, O
3 O
) O
anxiety O
disorders O
, O
and O
4 O
) O
significant O
alcohol O
use O
. O

We O
additionally O
explored O
and O
controlled O
for O
the O
effects O
of O
IQ O
and O
SES O
on O
our O
group O
differences O
in O
conflict-related O
activation O
and O
connectivity O
by O
conducting O
ROI-based O
analyses O
using O
the O
extracted O
parameter O
estimates O
from O
each O
significant O
cluster O
detected O
in O
our O
main O
analyses O
. O

